You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Delhi records zero Covid-19 death for 3rd time in Feb, 134 new cases

No fresh death due to COVID-19 was recorded in Delhi on Wednesday, the third time single-day fatality count stood nil in February

Delhi | Coronavirus

Press Trust of India  |  New Delhi 

Coronavirus test, vaccine
A health worker in a PPE kit collects swab samples from a man to conduct tests for the Coronavirus disease (COVID-19), at New Delhi Railway Station in New Delhi on Tuesday.

No fresh death due to COVID-19 was recorded in on Wednesday, the third time single-day fatality count stood nil in February, while 134 new cases took the tally to 6,37,315, according to data shared by authorities.

On February 9, no fatality from COVID-19 was registered in the national capital, first time this month, and after a gap of nearly nine months.

No death from COVID-19 was recorded on Saturday as well, the second time in February when the single-day fatality count was nil.

On Wednesday, recorded 134 fresh COVID-19 cases, while the positivity rate stood at 0.22 per cent, authorities said, adding that the tally in the city rose to 6,37,315.

One fatality was registered on Tuesday, taking the death toll in the city to 10,894, according to the health bulletin issued by the city government a day earlier.

recorded 94 fresh COVID-19 cases on Tuesday, the lowest in over nine months, while the positivity rate had slipped to 0.17 per cent.

Delhi had recorded 96 cases on January 27, that time the lowest in over nine months, and the first time the daily count had stood below the 100-mark in that month.

Also, on February 5 and 7, the fatality counts were two on both the days, same as on February 2.

These new 134 cases came out of the 59,886 tests conducted the previous day, according to the health bulletin.

The active cases tally on Wednesday rose to 1078 from 1036 the previous day, according to the bulletin.

The total number of tests conducted the previous day, included 39,852 RT-PCR tests and 20,034 rapid antigen tests, the bulletin said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, February 17 2021. 23:34 IST